e-learning
resources
Stockholm 2002
Sunday 15.09.2002
High altitude and hypoxia
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary hypertension due to COPD at high altitude
A. S. Sarybaev, A. S. Sydykov, A. M. Maripov, M. M. Kasymov, M. M. Mirrakhimov (Bishkek, Kyrgyzstan)
Source:
Annual Congress 2002 - High altitude and hypoxia
Session:
High altitude and hypoxia
Session type:
Thematic Poster Session
Number:
697
Disease area:
Pulmonary vascular diseases
Abstract
Rationale: COPD is frequently complicated by pulmonary hypertension (PH). Permanent residence at high altitude (above 3.000m) also leads to increase in pulmonary artery pressure and development of PH. Aim: to investigate the particularities of pulmonary circulation in highlanders (HL) with COPD. Methods: invasive measurements of pulmonary hemodynamis were performed in 23 male HL with COPD (2.400-2.700m) on the 7th day after descent to lowland (760m) and in 33 age matched male lowlanders (LL)(760m). All the measurements obtained were recorded at baseline while room air breathing and during hypoxic challenge (breathing gas mixture with FiO2=10% for 30 min). Results are presented in the table. Conclusion. Thus in HL even with moderate COPD severe PH and right ventricular (RV) hypertrophy are occur. Hyperreactivity of pulmonary vascular bed to acute hypoxia is also characteristic in this group of patients.
Legend. Group 1 - HL with moderate COPD; group 2 - LL with moderate COPD; group 3 - LL with severe COPD; RVAWT - RV anterior wall thickness; RVD - RV dimension; p - value of significance.
Group 1
Group 2
Group 3
P1-2
P2-3
P1-3
MPAP (mm Hg)
Room air
38.4±]1.7
24.7±]1.2
33.0±]1.2
0.000
0.000
0.013
Hypoxia
48.7±]2.1
33.9±]2.0
40.6±]1.5
0.001
0.013
0.021
SaO2 (%)
Room air
90.2±]1.0
91.3±]0.9
89.7±]1.3
0.492
0.319
0.761
Hypoxia
65.8±]2.2
67.3±]1.7
64.8±]1.7
0.108
0.022
0.479
RVAWT (cm)
0.59±]0.02
0.46±]0.03
0.52±]0.02
0.029
1.0
0.003
RVD (cm)
2.7±]0.1
2.2±]0.1
2.6±]0.1
0.004
0.017
0.484
FEV1, % pred
47.1±]4.5
43.5±]3.5
25.8±]1.2
0.524
0.000
0.000
FEV1/FVC, (%)
51.7±]3.2
48.4±]2.3
38.4±]2.1
0.401
0.000
0.000
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. S. Sarybaev, A. S. Sydykov, A. M. Maripov, M. M. Kasymov, M. M. Mirrakhimov (Bishkek, Kyrgyzstan). Pulmonary hypertension due to COPD at high altitude. Eur Respir J 2002; 20: Suppl. 38, 697
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
The definition of pulmonary hypertension: history, practical implications and current controversies
Related content which might interest you:
State of β-adrenoreceptors in pulmonary hypertension due to COPD at high altitude
Source: Eur Respir J 2002; 20: Suppl. 38, 99s
Year: 2002
Endothelin and high altitude pulmonary hypertension
Source: Annual Congress 2008 - Pulmonary arterial hypertension and other pulmonary vascular diseases
Year: 2008
High-altitude disease
Source: Respipedia Article
Year: 2017
Pulmonary hypertension reduces exercise tolerance in COPD
Source: Annual Congress 2010 - Pulmonary circulation III
Year: 2010
Cerebral oxygenation in highlanders with high altitude pulmonary hypertension
Source: Annual Congress 2013 –Clinical physiology and functional imaging in health and disease
Year: 2013
The prevalence and characteristics of pulmonary hypertension in severe COPD
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016
Common genetic basis for pulmonary arterial hypertension and high altitude pulmonary edema
Source: International Congress 2018 – Experimental research in pulmonary hypertension
Year: 2018
Co-morbidities and pulmonary arterial hypertension (PAH) in COPD patients
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016
Pulmonary hypertension, and exercise tolerance in patients with COPD exacerbation
Source: Annual Congress 2010 - Pulmonary circulation: clinical aspects
Year: 2010
Prevalence of established and exercise induced pulmonary hypertension in COPD
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011
Right and left ventricular function in lowlanders with COPD travelling to moderate altitude
Source: International Congress 2015 – Pulmonary hypertension in lung disease
Year: 2015
Pulmonary hypertension at the patients with bronchial asthma and COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 58s
Year: 2004
Pulmonary hypertension and exercise performance in advanced COPD
Source: Annual Congress 2011 - Pulmonary hypertension in hypoxic lung disease
Year: 2011
Comparison of exercise capacity and exercise haemodynamic relationships between severe group 3 pulmonary hypertension and pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016
NT-proBNP in assessment of pulmonary hypertension in COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013
Pulmonary hypertension in COPD
Source: Eur Respir J 2008; 32: 1371-1385
Year: 2008
Pulmonary hypertension in a COPD Patient
Source: Virtual Congress 2020 – Pulmonary vascular diseases
Year: 2020
Pulmonary hypertension in COPD: Prevalence and characteristics
Source: Annual Congress 2012 - COPD comorbidities II
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept